Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice

Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome proliferator-activated receptor α (PPARα), a nuclear receptor that regulates the expression of metabolic genes able to control lipid metabolism and food intake. PPARα natural ligands include fatty acids (...

Descripción completa

Detalles Bibliográficos
Autores principales: Murru, Elisabetta, Muntoni, Anna Lisa, Manca, Claudia, Aroni, Sonia, Pistis, Marco, Banni, Sebastiano, Carta, Gianfranca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821630/
https://www.ncbi.nlm.nih.gov/pubmed/36614161
http://dx.doi.org/10.3390/ijms24010709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821630/
https://www.ncbi.nlm.nih.gov/pubmed/36614161
http://dx.doi.org/10.3390/ijms24010709

Ejemplares similares